BARACLUDE - 0003-1611-13 - (entecavir)

Alphabetical Index


Drug Information of BARACLUDE

Product NDC: 0003-1611
Proprietary Name: BARACLUDE
Non Proprietary Name: entecavir
Active Ingredient(s): .5    mg/1 & nbsp;   entecavir
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of BARACLUDE

Product NDC: 0003-1611
Labeler Name: E.R. Squibb & Sons, L.L.C.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021797
Marketing Category: NDA
Start Marketing Date: 20050329

Package Information of BARACLUDE

Package NDC: 0003-1611-13
Package Description: 90 TABLET, FILM COATED in 1 BOTTLE (0003-1611-13)

NDC Information of BARACLUDE

NDC Code 0003-1611-13
Proprietary Name BARACLUDE
Package Description 90 TABLET, FILM COATED in 1 BOTTLE (0003-1611-13)
Product NDC 0003-1611
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name entecavir
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20050329
Marketing Category Name NDA
Labeler Name E.R. Squibb & Sons, L.L.C.
Substance Name ENTECAVIR
Strength Number .5
Strength Unit mg/1
Pharmaceutical Classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of BARACLUDE


General Information